Literature DB >> 9626131

Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system.

J E Nestler1, D J Jakubowicz, A F de Vargas, C Brik, N Quintero, F Medina.   

Abstract

To determine whether insulin stimulates human ovarian testosterone production in the polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system, thecal cells from polycystic ovary syndrome women were isolated and cultured. Insulin and insulin-like growth factor I stimulated thecal testosterone biosynthesis. Antibody blockade of the insulin receptor abolished insulin's stimulatory action, whereas effective antibody blockade of the insulin-like growth factor I receptor did not alter insulin's stimulation of thecal testosterone biosynthesis. A chiro-inositol containing glycan (INS-2) increased thecal testosterone biosynthesis. Preincubation of cells with an antiinositolglycan antibody (A23939 or alpha IGP) abolished insulin's stimulatory effect, but not that of hCG. These findings suggest that inositolglycans serve as the signal transduction system for insulin's stimulation of human thecal testosterone biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626131     DOI: 10.1210/jcem.83.6.4886

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  146 in total

Review 1.  Multiple signal transduction pathways regulate ovarian steroidogenesis.

Authors:  Jennifer R Wood; Jerome F Strauss
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

Review 2.  The ovarian androgen-producing cells: a 2001 perspective.

Authors:  Denis A Magoffin
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

Review 3.  Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions.

Authors:  Kristen Farrell; Michael H Antoni
Journal:  Fertil Steril       Date:  2010-05-14       Impact factor: 7.329

4.  The biological activity of structurally defined inositol glycans.

Authors:  Meenakshi Goel; Viatcheslav N Azev; Marc d'Alarcao
Journal:  Future Med Chem       Date:  2009-04       Impact factor: 3.808

5.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

Review 6.  Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?

Authors:  Jean-Patrice Baillargeon; John E Nestler
Journal:  J Clin Endocrinol Metab       Date:  2005-11-01       Impact factor: 5.958

Review 7.  [Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome].

Authors:  D Heutling; H Schulz; H Randeva; C Dodt; H Lehnert
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

8.  Gonadal dysfunction in morbidly obese adolescent girls.

Authors:  Vivian Chin; Marisa Censani; Shulamit Lerner; Rushika Conroy; Sharon Oberfield; Donald McMahon; Jeffrey Zitsman; Ilene Fennoy
Journal:  Fertil Steril       Date:  2014-02-26       Impact factor: 7.329

9.  Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretion.

Authors:  C M Burt Solorzano; C R McCartney; S K Blank; K L Knudsen; J C Marshall
Journal:  BJOG       Date:  2010-01       Impact factor: 6.531

10.  Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}.

Authors:  Gregorio Chazenbalk; Bradley S Trivax; Bulent O Yildiz; Cristina Bertolotto; Ruchi Mathur; Saleh Heneidi; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.